Chemical and Pharmaceutical Bulletin p. 84 - 96 (1998)
Update date:2022-08-05
Topics:
Seki, Toshimi
Kanada, Arihiro
Nakao, Tomio
Shiraiwa, Masahumi
Asano, Hajime
Miyazawa, Katuhiko
Ishimori, Tsutomu
Minami, Nobuyoshi
Shibata, Kenyu
Yasuda, Kikuo
Synthesis of the four optical isomers of TZC-5665 (1), a candidate for the treatment of congestive heart failure, was achieved by the reaction of chiral diaminopyridazinone (2) with chiral glycidyl ether (3). The hypotensive and β-blocking activities of 1 and its optical isomers were examined when given intravenously into anesthetized rats. Furthermore these compounds were evaluated for inhibitory activity on cAMP phosphodiesterase III. Among the four optical isomers, R(A),S(B)-one (1c) possessed the essential activities of TZC-5665 (1).
View MoreContact:+86-633-8332928
Address:No.1,Huanghai Yilu.Rizhao,Shandong
Baoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Contact:86-21-58226973
Address:No 351,Guoshoujing Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China
LIANYUNGANG YC FINE CHEMICAL CO., LTD
Contact:+86-518-858 99188
Address:Shangdong Modern Bldg, South Greenpark Road, Lianyungang, Jiangsu Pro. China
Doi:10.1021/ja01083a022
(1965)Doi:10.1002/hlca.19680510627
(1968)Doi:10.1021/jo971995f
(1998)Doi:10.1002/anie.201304691
(2013)Doi:10.1039/a707354b
(1998)Doi:10.1016/S0957-4166(97)00617-4
(1998)